CRGX250117P10000
- 0.00
- 0.000.00%
CARGO Therapeutics Newsroom
How Cutting-Edge Immunotherapies Are Redefining Cancer Treatment Options
Clear Street Launches Healthcare & Biotechnology Equity Research
CARGO Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference
Down -14.13% in 4 Weeks, Here's Why CARGO Therapeutics, Inc. (CRGX) Looks Ripe for a Turnaround
Bears Are Losing Control Over CARGO Therapeutics, Inc. (CRGX), Here's Why It's a 'Buy' Now
Truist Financial Maintains CARGO Therapeutics(CRGX.US) With Buy Rating
CARGO Therapeutics, Inc. (CRGX) Receives a Buy From Truist Financial
William Blair Maintains CARGO Therapeutics(CRGX.US) With Buy Rating
CARGO Therapeutics, Inc.: Buy Rating Backed by Promising CAR-T Developments and Positive Clinical Data
Express News | CARGO Therapeutics : Sales Agreement Prospectus Covering Offering of up to $200 Mln of Common Stock That May Be Issued From Time to Time
Express News | CARGO Therapeutics Inc Files for Mixed Shelf- SEC Filing
We're Not Very Worried About CARGO Therapeutics' (NASDAQ:CRGX) Cash Burn Rate
Cargo Therapeutics Draws Bullish View at William Blair on Lead Asset
William Blair Initiates Coverage On Cargo Therapeutics With Outperform Rating
William Blair Initiates CARGO Therapeutics(CRGX.US) With Buy Rating
H.C. Wainwright Maintains CARGO Therapeutics(CRGX.US) With Buy Rating, Maintains Target Price $33
Promising Outlook for Cargo Therapeutics: Buy Rating Backed by Strong Financials and Clinical Developments
Truist Financial Maintains CARGO Therapeutics(CRGX.US) With Buy Rating, Maintains Target Price $32
CARGO Therapeutics Advances in Cancer Therapy Development
Chardan Capital Maintains CARGO Therapeutics(CRGX.US) With Buy Rating, Maintains Target Price $28